NasdaqGS:DXCMMedical Equipment
Is It Time To Revisit DexCom (DXCM) After Share Price Weakness And DCF Upside?
Wondering if DexCom at around US$61.63 is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio?
The share price has inched up about 1.7% over the past week and 0.7% over the past month, but is still down about 7.4% year to date and has declined about 27.9% over the past year.
Recent headlines have focused on DexCom's role in continuous glucose monitoring and how that fits into broader healthcare technology trends, which can shape how...